Physician profile
Stephen L Moore
NPI 1992785018
$4,098.95
in general payments reported to CMS, 2019-2025
31 companies · $72.64 in 2025
The $72.64 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $268 · 2020: $466 · 2021: $519 · 2022: $1,752 · 2023: $39.24 · 2024: $982 · 2025: $72.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $589 · Travel and Lodging: $505.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $589.02 |
| Travel and Lodging | $505.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,060.24 | 2021-2024 | Micra |
| Janssen Pharmaceuticals, INC | $616.57 | 2019-2023 | Xarelto |
| Sanofi-Aventis U.S. LLC | $218.89 | 2019-2022 | |
| Abbott Laboratories | $147.23 | 2021-2025 | Cardiomems |
| Actelion Pharmaceuticals US, INC. | $129.76 | 2019-2024 | Opsumit, Uptravi |
| Pfizer INC. | $104.88 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $98.33 | 2021-2022 | |
| Elutia, INC. | $81.93 | 2020-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $74.20 | 2019-2020 | |
| Amarin Pharma, INC. | $60.23 | 2020-2021 | |
| Grifols USA, LLC | $57.08 | 2020-2022 | |
| Amgen INC. | $48.41 | 2019-2021 | |
| Chiesi USA, INC. | $40.85 | 2019-2020 | |
| Philips North America LLC | $40.68 | 2020 | |
| Harmony Biosciences LLC | $38.00 | 2020-2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $28.42 | 2022 | |
| Novo Nordisk INC | $27.34 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $26.86 | 2020 | |
| Jazz Pharmaceuticals INC. | $20.50 | 2019 | |
| Biosense Webster, INC. | $20.14 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $16.35 | 2021 | |
| Bardy Diagnostics, INC. | $16.23 | 2020 | |
| Novartis Pharmaceuticals Corporation | $15.90 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.64 | 2021 | |
| Portola Pharmaceuticals, LLC | $14.95 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $14.48 | 2021 | |
| Sunovion Pharmaceuticals INC. | $14.41 | 2019 | |
| Boston Scientific Corporation | $14.15 | 2022 | |
| Medtronic Vascular, INC. | $13.28 | 2019 | |
| Pulmonx Corporation | $11.62 | 2021 | |
| Merck Sharp & Dohme LLC | $11.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.